Eisai (4523) · InitiativeFirst stated
Continued sales after termination of the co-development and sales partnership agreement for Carelam (iguratimod)
First written in FY2023-Q2. . Latest entry: FY2023-Q2.
1entries
1years
0from disclosures
How it moved
Same theme, other companies
Continued Sales Through Exclusive Supply After Termination of the Carelam Co-development and Sales PartnershipA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.